Summary
The effects of neuropeptide Y (NPY), peptide YY (PYY), pancreatic polypeptide and of another four peptides on the electrically evoked 3H overflow were studied in superfused rat brain cortex slices preincubated with 3H-serotonin. In addition, we determined the effect of NPY on the Ca2+-induced 3H overflow from rat brain cortex slices and synaptosomes (preincubated with 3H-serotonin) and on the forskolin-stimulated accumulation of cAMP in a membrane fraction from rat brain cortex.
The electrically (3 Hz) evoked 3H overflow was inhibited by PYY, NPY and pancreatic polypeptide (decreasing order of potency), but not affected by ACTH1−24, angiotensin 11, bradykinin and delta-sleep-inducing peptide. The inhibitory effect of NPY did not change when the stimulation frequency was lowered to 1 Hz, but was markedly reduced at 10 Hz. The inhibitory effect of a presumably maximally active concentration of PYY was not altered in the presence of NPY or pancreatic polypeptide (effects not additive), whereas the inhibition produced by a maximally active concentration of the α2-adrenoceptor agonist clonidine was further increased by NPY. NPY also inhibited (1) the tritium overflow, evoked by introduction of Ca2+, in slices superfused with Ca2+-free and K+-rich medium containing tetrodotoxin, (2) the tritium overflow, evoked by simultaneously increasing Ca2+ and K+ in the superfusion fluid of synaptosomes previously superfused with Ca2+-free medium and (3) the forskolin-stimulated accumulation of cAMP in rat brain cortex membranes.
The present results suggest that NPY inhibits serotonin release in the rat brain via presynaptic NPY receptors, which are also activated by PYY and pancreatic polypeptide and may be negatively coupled to an denylate cyclase.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baumann PA, Waldmeier PC (1981) Further evidence for negative feedback control of serotonin release in the central nervous system. Naunyn-Schmiedeberg's Arch Pharmacol 317:36–43
Bottiglieri DF, Sumners C, Raizada MK (1987) Angiotensin II inhibits the K+-evoked release of [3H]norepinephrine from hypothalamic synaptosomes of the spontaneously hypertensive rat. Brain Res 403:167–171
Classen K, Göthert M, Schlicker E (1984) Effects of DU 24565 (6-nitroquipazine) on serotoninergic and noradrenergic neurones of the rat brain and comparison with the effects of quipazine. Naunyn-Schmiedeberg's Arch Pharmacol 326:198–202
Endo T, Starke K, Bangerter A, Taube HD (1977) Presynaptic receptor systems on the noradrenergic neurones of the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 296:229–247
Göthert M (1980) Serotonin-receptor-mediated modulation of Ca2+-dependent 5-hydroxytryptamine release from neurones of the rat brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 314:223–230
Göthert M (1981) ACTH1−24 increases stimulation-evoked noradrenaline release from sympathetic nerves by acting on presynaptic ACTH receptors. Eur J Pharmacol 76:295–296
Göthert M (1984) Facilitatory effect of adrenocorticotropic hormone and related peptides on Ca2+-dependent noradrenaline release from sympathetic nerves. Neuroscience 11:1001–1009
Göthert M (1985) Role of autoreceptors in the function of the peripheral and central nervous system. Arzneimittelforschung (Drug Res) 35:1909–1916
Göthert M, Schlicker E (1990) Regulation of serotonin release in the central nervous system by presynaptic heteroreceptors. In: Feigenbaum J, Hanani M (eds) Presynaptic regulation of neurotransmitter release: a handbook. Freund, Tel Aviv (in press)
Groß G, Hante K, Göthert M (1987) Effect of antidepressant and neuroleptic drugs on the electrically evoked release of serotonin from rat cerebral cortex. Psychopharmacology 91:175–181
Llona I, Prieto A (1984) Bradicinina: un neuromodulador simpatico. Arch Biol Med Exp 17:R153
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Martire M, Fuxe K, Pistritto G, Preziosi P, Agnati LF (1989) Neuropeptide Y increases the inhibitory effects of clonidine on potassium evoked 3H-noradrenaline but not 3H-5-hydroxytryptamine release from synaptosomes of the hypothalamus and the frontoparietal cortex of the male Sprague-Dawley rat. J Neural Transm 78:61–72
Michel MC, Schlicker E, Fink K, Boublik JH, Göthert M, Willette RN, Daly RN, Hieble JP, Rivier JE, Motulsky HJ (1990) Distinction of NPY receptor subtypes in vitro and in vivo: I. NPY18–36 discriminates between NPY receptor subtypes in vitro. Am J Physiol 259:E131-E139
Moret C (1985) Pharmacology of the serotonin autoreceptor. In: Green AR (ed) Neuropharmacology of serotonin. Oxford University Press, Oxford New York Toronto Melbourne, pp 21–49
Moret C, Briley M (1990) Modulation by drugs of the release of total tritium and 3H-5-HT from rat hypothalamic slices. Naunyn-Schmiedeberg's Arch Pharmacol 341:398–403
Mulder AH, van den Berg WB, Stoof JC (1975) Calcium-dependent release of radiolabeled catecholamines and serotonin from rat brain synaptosomes in a superfusion system. Brain Res 99:419–424
Nakamura A, Nakashima M, Sakai K, Niwa M, Nozaki M, Shiomi H (1989) Delta-sleep-inducing peptide (DSIP) stimulates the release of immunoreactive Met-enkephalin from rat lower brainstem slices in vitro. Brain Res 481:165–168
Petrenko S, Olianas MC, Onali P, Gessa L (1987) Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase activity in rat hippocampus. Eur J Pharmacol 136:425–428
Potter EK (1988) Neuropeptide Y as an autonomic neurotransmitter. Pharmacol Ther 37:251–273
Schlicker E, Fink K, Göthert M (1989a) Effects of neuropeptide Y, ACTH 1–24, angiotensin II and bradykinin on serotonin release in the rat brain (abstr. 51). The neuropharmacology of serotonin Conference. New York Academy of Sciences, New York
Schlicker E, Fink K, Göthert M (1989b) Neuropeptide Y (NPY) inhibits serotonin release in the rat brain cortex at a presynaptic site. Naunyn-Schmiedeberg's Arch Pharmacol 340(Suppl):R25
Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1–124
Starke K, Göthert M, Kilbinger H (1989) Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev 69:864–989
Wahlestedt C, Håkanson R (1986) Effects of neuropeptide Y (NPY) on the sympathetic neuroeffector junction. Can pre-, postjunctional receptors be distinguished? Med Biol 64:85–88
Westfall TC, Martin J, Chen X, Ciarleglio A, Carpentier S, Henderson K, Knuepfer M, Beinfeld M, Naes L (1988) Cardiovascular effects and modulation of noradrenergic neurotransmission following central and peripheral administration of neuropeptide Y. Synapse 2:299–307
Westlind-Danielsson A, Andell S, Abens J, Bartfai T (1988) Neuropeptide Y and peptide YY inhibit adenylate cyclase activity in the rat striatum. Acta Physiol Scand 132:425–430
Yokoo H, Schlesinger DH, Goldstein M (1987) The effect of neuropeptide Y (NPY) on stimulation-evoked release of [3H]norepinephrine (NE) from rat hypothalamic and cerebral cortical slices. Eur J Pharmacol 143:283–286
Author information
Authors and Affiliations
Additional information
Send offprint requests to E. Schlicker at the above address
Rights and permissions
About this article
Cite this article
Schlicker, E., Groß, G., Fink, K. et al. Serotonin release in the rat brain cortex is inhibited by neuropeptide Y but not affected by ACTH1–24 angiotensin II, bradykinin and delta-sleep-inducing peptide. Naunyn-Schmiedeberg's Arch Pharmacol 343, 117–122 (1991). https://doi.org/10.1007/BF00168597
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00168597